Telix Pharmaceuticals Limited (ASX:TLX)
14.37
-0.23 (-1.58%)
Sep 1, 2025, 10:26 AM AEST
Telix Pharmaceuticals Employees
Telix Pharmaceuticals had 234 employees as of December 31, 2022. The number of employees increased by 76 or 48.10% compared to the previous year.
Employees
234
Change (1Y)
76
Growth (1Y)
48.10%
Revenue / Employee
2.40M AUD
Profits / Employee
39.10K AUD
Market Cap
4.94B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 234 | 76 | 48.10% |
Dec 31, 2021 | 158 | 149 | 1,655.56% |
Dec 31, 2017 | 9 | - | - |
Related Stocks
Company Name | Employees |
---|---|
CSL Limited | 29,904 |
Pro Medicus | 132 |
Cochlear | 5,500 |
Sonic Healthcare | 42,000 |
Ramsay Health Care | 90,000 |
Ansell | 15,000 |
Mesoblast | 73 |
Neuren Pharmaceuticals | 8 |
Telix Pharmaceuticals News
- 2 days ago - Telix Pharmaceuticals Limited (TLX) Hits Another Roadblock After SEC Subpoena, Shares Fall Again -- Hagens Berman - GlobeNewsWire
- 2 days ago - Telix Pharmaceuticals: Roadblocks Piling Up, But They're Not Insurmountable - Seeking Alpha
- 2 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX - GlobeNewsWire
- 3 days ago - Telix Gets Second FDA Rejection For Kidney Cancer Drug - Benzinga
- 3 days ago - Telix Gets Second FDA Rejection For Kidney Cancer Drug - Benzinga
- 3 days ago - US FDA seeks more information on Telix Pharma's diagnostic drug for kidney cancer - Reuters
- 4 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited - TLX - PRNewsWire
- 5 days ago - Telix Pharmaceuticals Limited (TLX) Shares Fall Amid SEC Subpoena -- Hagens Berman - GlobeNewsWire